echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Eur Urol Focus: Chromosomal instability of cell-free DNA can serve as a prognostic biomarker for androgen deprivation in the treatment of metastatic hormone-sensitive prostate cancer

    Eur Urol Focus: Chromosomal instability of cell-free DNA can serve as a prognostic biomarker for androgen deprivation in the treatment of metastatic hormone-sensitive prostate cancer

    • Last Update: 2022-10-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Although patients with metastatic hormone-sensitive prostate cancer (mHSPC) can be treated with androgen deprivation therapy (ADT), metastases can still progress to anti-prostate cancer (mCRPC


    Recently, researchers from South Korea published an article in Eur Urol Focus investigating the role


    This prospective study included 75 patients with elevated prostate-specific antigens, analyzed their cell-free DNA (cfDNA) in pre-treatment plasma samples, and performed low-depth whole-genome sequencing of cfDNA to identify CNAs


    Of the 22 IScore-positive patients, 86.


    Different factors predict the development of castration resistance

    Taken together, IScore can serve as a biomarker


    Original Source:

    Chung Un Lee, Eunhae Cho, Junnam Lee et al.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.